Current Essential Testing in Early Breast Cancer
English
Recorded Courses
hosted by Clinical Care Options (CCO), LLC
hosted by Clinical Care Options (CCO), LLC
attend it anywhere online
category
Pharmacy, Medicine, Nursing, Healthcare Management
Nurse Practitioners, Oncology
price
Free
Current Essential Testing in Early Breast Cancer is organized by Clinical Care Options (CCO), LLC.,Released: March 31, 2023,Expiration: March 30, 2024,Program Learning Goal:,The goal of this activity is to improve the knowledge, confidence, and competence of learners to select and integrate new biomarker testing and therapies into individualized treatment plans for early-stage breast cancer.,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Develop genetic testing strategies that incorporate best communication techniques and expert guidance for all patient subgroups with EBC who may benefit from PARP inhibition,• Communicate to colleagues and patients the improvement in overall survival gained by adding PARP inhibition to the adjuvant treatment of patients with germline BRCA mutations,• Integrate PARP inhibition into treatment plans and sequence strategies for patients that also may be appropriate for other newly approved treatments for EBC,• Manage treatment-related adverse events in the early-stage breast cancer setting associated with new treatment options to improve adherence and patient experience and optimize outcomes,• Identify patients who should be tested for BRCA mutations and communicate to colleagues and patients the rationale and steps for corrective action for those not tested